|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based compensation | |||||
| Amortization of right of use assets | |||||
| Amortization of contract cost assets | |||||
| Amortization of debt discount and debt issuance costs | |||||
| Gain (loss) on extinguishment of debt | |||||
| Loss (gain) on extinguishment of debt | |||||
| Impairment and restructuring costs | |||||
| Inventory valuation adjustment | |||||
| Impairment costs | |||||
| Accretion of bond discount | |||||
| Other adjustments to reconcile net income (loss) to net cash provided by operating activities | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Mortgage loans held for sale | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Contract cost assets | |||||
| Lease liabilities | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Accrued compensation and benefits | |||||
| Deferred revenue | |||||
| Other long-term liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Proceeds from maturities of investments | |||||
| Proceeds from sales of investments | |||||
| Purchases of investments | |||||
| Purchases of property and equipment | |||||
| Purchases of intangible assets | |||||
| Cash paid for acquisitions, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities | |||||
| Proceeds from issuance of Class C capital stock, net of issuance costs | |||||
| Proceeds from issuance of term loan, net of issuance costs | |||||
| Repayments of borrowings on credit facilities | |||||
| Net borrowings on warehouse line of credit and repurchase agreements | |||||
| Repurchases of Class A common stock and Class C capital stock | |||||
| Settlement of convertible senior notes | |||||
| Settlement of capped call transactions | |||||
| Proceeds from exercise of stock options | |||||
| Payment for Contingent Consideration Liability, Financing Activities | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash during period | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for taxes | |||||
| Noncash transactions: | |||||
| Write-off of fully depreciated property and equipment | |||||
| Write-off of fully amortized intangible assets | |||||
| Capitalized share-based compensation | |||||
| Initial fair value of contingent consideration recognized in connection with an acquisition | |||||
| Value of Class C capital stock issued in connection with an acquisition | |||||
| Settlement of beneficial interests in securitizations | |||||
Loading...